New Rapid Acting Apidra(tm) Insulin

New FDA approved insulin will be available soon. New Rapid Acting Apidra(tm) Insulin
APIDRA(tm) (insulin glulisine [rDNA origin]) is a human insulin analog that is a rapid-acting, parenteral blood glucose lowering agent. Approved for SQ injections and also for use in insulin pumps. Similar in action to Humalog and Novolog. Now Aventis has it’s long acting insulin Lantus(tm) and its rapid acting insulin Apidra(tm) More info